Cofoe Medical Technology Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
December 29, 2022 at 11:00 am EST
Share
Cofoe Medical Technology Co.,Ltd. (SZSE:301087) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The share will be repurchased at a price not more than CNY 60 per share. The repurchased shares will be used for employee stock ownership plans or equity incentives. The program will be valid for a period of 12 months.
On May 18, 2023, the company adjusted the upper limit of the repurchase price to CNY 58.82 per share.
Cofoe Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and service of household medical devices. The Company owns the Cofoe brand. The Company's products include health monitoring, rehabilitation aids, medical care, traditional Chinese medicine physiotherapy, respiratory support and others, such as blood pressure monitors, infrared thermometers, nursing beds, wheelchairs, nebulizers, moxibustion series, health protection supplies, etc. The Company conducts its businesses within the domestic market and to overseas markets.